Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PPB Approval

CONTRAVE PROLONGED-RELEASE TABLETS 8MG/90MG

Registration Code

HK-66934

Sale Requirement

Prescription only Medicines

Registration Date

December 10, 2020

Company NameiNOVA Pharmaceuticals (Hong Kong) Limited

Company Information

Company Details

Company NameiNOVA Pharmaceuticals (Hong Kong) Limited

Company Address

UNIT 2506 TOWER 1, 25/F, ENTERPRISE SQUARE FIVE, 38 WANG CHIU ROAD, KOWLOON BAY, KOWLOON

Active Ingredients

Ingredient Name

Bupropion hydrochloride

Ingredient ID

b57d25a70a1e6634

Ingredient Name

Naltrexone hydrochloride

Ingredient ID

eb39f9eabdb9a23e

Drug Monographs

English NameBupropion

Chinese Name

安非他酮

English NameNaltrexone

Chinese Name

纳曲酮

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

CONTRAVE PROLONGED-RELEASE TABLETS 8MG/90MG - PPB 批准文号 | MedPath